![]() ![]() Product availability may vary by retailer ǁǁ Participating pharmacies are subject to change without notice. No YSI measurements were obtained for children 4-5 years of age. ‡‡ Calculated based on the number of CGM and YSI paired readings at glucose ranges <54 mg and 54-69 mg/dL, respectively. †† MARD (mean absolute relative difference) is compared to reference YSI values. ** Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 2 User’s Manual for more information. # Notifications will only be received when alarms are turned on and the sensor is within 20 feet unobstructed of the reading device. ¶ FreeStyle Libre 2 system is indicated for use in people with diabetes age 4 and older. Fingersticks are required for treatment decisions when you see the Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations. ǁ The FreeStyle Libre 2 app and the FreeStyle Libre 2 reader have similar but not identical features. Use of the FreeStyle Libre 2 app requires registration with LibreView. Please check our compatibility guide for more information about device compatibility before using the app. ![]() § The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any. ‡ Based on a comparison of list prices of the FreeStyle Libre 2 system versus competitors' CGM systems. Participating pharmacies are subject to change without notice. This does not apply to beneficiaries of Medicare, Medicaid, or other federal or state healthcare programs. This applies to commercially insured patients. † No paperwork hassles or prior authorization needed at participating pharmacies. Therefore, the study data is applicable to both products. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional real-time glucose alarms. * Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Medicare and other third party payor criteria apply.Ībbott provides this information as a courtesy, it is subject to change and interpretation. This real-world, chart review study concluded that people with T2DM on insulin therapy, using FreeStyle Libre for between 3 – 6 months significantly reduced HbA1c.Medicare coverage is available for the FreeStyle Libre 2 system if the FreeStyle Libre 2 reader is used to review glucose data on some days every month. To minimise selection bias, all patients that had used FreeStyle Libre for at least 3 months from each study site were included in the analysis.Īfter at least 3 months of using FreeStyle Libre, HbA1c (primary outcome) was significantly reduced by 0.9 ± 1.1% (mean ± SD) p < 0.0001. ![]() HbA1c results were recorded between 90 – 194 days from the start of use of FreeStyle Libre, between September 2015 and August 2018. On average, HbA1c was 8.9 ± 0.9% (73.1 ± 10.3 mmol/mol), prior to FreeStyle Libre use, age was 62.7 ± 11.8 years and average duration of insulin use 7.8 ± 5.4 years (mean ± SD), 67% of patients were on oral anti-diabetic medications (metformin, SU, TZD, DPP4 or SGLT2) and 57.1% were male. Adults on a basal-bolus insulin regimen for at least 1 year, using FreeStyle Libre regularly for at least 3 months (either self-funded or prescribed) and with HbA1c between 8.0 and 12.0% (64 to 108 mmol/mol) were included.Ī total of 183 records from insulin using patients with T2DM from 6 medical centres in Germany were included in this chart review. This study aimed to determine the effect of FreeStyle Libre when used for between 3 – 6 months on HbA1c. This retrospective chart review study evaluated the effectiveness of the FreeStyle Libre Flash Glucose Monitoring SystemTM when used by adults with type 2 diabetes (T2DM) in a real-world setting. ![]()
0 Comments
Leave a Reply. |